JP2024069430A5 - - Google Patents

Download PDF

Info

Publication number
JP2024069430A5
JP2024069430A5 JP2024038955A JP2024038955A JP2024069430A5 JP 2024069430 A5 JP2024069430 A5 JP 2024069430A5 JP 2024038955 A JP2024038955 A JP 2024038955A JP 2024038955 A JP2024038955 A JP 2024038955A JP 2024069430 A5 JP2024069430 A5 JP 2024069430A5
Authority
JP
Japan
Prior art keywords
vector
aspartic acid
asparagine
amino acids
repeat sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024038955A
Other languages
English (en)
Japanese (ja)
Other versions
JP7854207B2 (ja
JP2024069430A (ja
Filing date
Publication date
Priority claimed from PCT/JP2022/019038 external-priority patent/WO2022230924A1/ja
Application filed filed Critical
Publication of JP2024069430A publication Critical patent/JP2024069430A/ja
Publication of JP2024069430A5 publication Critical patent/JP2024069430A5/ja
Application granted granted Critical
Publication of JP7854207B2 publication Critical patent/JP7854207B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024038955A 2021-04-30 2024-03-13 筋強直性ジストロフィー１型治療薬 Active JP7854207B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021077262 2021-04-30
JP2021077262 2021-04-30
PCT/JP2022/019038 WO2022230924A1 (ja) 2021-04-30 2022-04-27 筋強直性ジストロフィー１型治療薬
JP2023517588A JP7461687B2 (ja) 2021-04-30 2022-04-27 筋強直性ジストロフィー１型治療薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023517588A Division JP7461687B2 (ja) 2021-04-30 2022-04-27 筋強直性ジストロフィー１型治療薬

Publications (3)

Publication Number Publication Date
JP2024069430A JP2024069430A (ja) 2024-05-21
JP2024069430A5 true JP2024069430A5 (https=) 2025-04-08
JP7854207B2 JP7854207B2 (ja) 2026-05-01

Family

ID=

Similar Documents

Publication Publication Date Title
JP2024010112A5 (https=)
ES3052719T3 (en) Polynucleotides and vectors for the expression of transgenes
JPWO2022020616A5 (https=)
JP2021512649A5 (https=)
JP2024100936A5 (https=)
JP2022066336A5 (https=)
IL259595B2 (en) Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
JP2020511167A5 (https=)
JP2024099833A5 (https=)
JP2024099834A5 (https=)
JP2003505033A5 (https=)
IL273394B1 (en) Variant rnai
US20220348613A1 (en) Adeno-associated viruses and methods and materials for making and using adeno-associated viruses
JP2024102242A5 (https=)
US20220162638A1 (en) Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer
JP2021534766A5 (https=)
JPWO2021007529A5 (https=)
JPWO2020214609A5 (https=)
JP2024069430A5 (https=)
JP2024119900A5 (https=)
JPWO2019204593A5 (https=)
JP2025516136A5 (https=)
JPWO2021226008A5 (https=)
JPWO2021108809A5 (https=)
RU2023130413A (ru) Лекарственное средство для лечения миотонической дистрофии 1-го типа